China International Neuroscience Institution
14
0
0
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
50%
7 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Assessing the Time-Course of Dexmedetomidine-Induced Analgesia Via EEG
Role: lead
Brain Regions and Functional Neuronal Network Characteristics of Dexmedetomidine Analgesia
Role: lead
Preemptive Analgesia Of Dexmedetomidine Reduces Per-operation Pain
Role: lead
ED50 of Sufentanil for Intraoperative Analgesia
Role: lead
Effects of Crystal Solution and Colloid Solution on Mother and Fetus
Role: lead
Dexmedetomidine Facilitate Analgesia
Role: lead
Different Anesthesia Maintain Protocol Effect the Outcome of the Patients
Role: lead
Comparation Analgesia Efficiency With Propofol Combine Sevoflurane vs Propofol
Role: lead
The Phenylephrine vs. Norepinephrine Infusion Undergoing Cesarean Section
Role: lead
The Correlation Between Sevoflurane and qNOX
Role: lead
ED50 of Cis-atracurium for Laryngeal Mask Incubation in General Anesthesia
Role: lead
Blood microRNA Depression Change After DHCA
Role: lead
The Relationship Among rSO2, MAP, et al by Near-Infrared Spectroscopy in Endovascular Neurosurgery
Role: lead
Temperature and Analgesia Monitoring During Cardial Parmonary Bypass
Role: lead
All 14 trials loaded